Status:
WITHDRAWN
Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate Cancer
Lead Sponsor:
University of Bath
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Prostate cancer is the cause of the greatest number of years lived with disability due to cancer. Treatment for prostate cancer is associated with significant side effects, such as fatigue, loss of mu...
Detailed Description
Background Among all cancers, the diagnosis of prostate cancer is associated with the greatest number of years lived with the disability and side effects of cancer. The treatment of men with prostate...
Eligibility Criteria
Inclusion
- For this pilot study, we will aim to recruit a total of 30 patients who have been diagnosed with prostate cancer. They will be recruited from a number of Gloucestershire-based sites; a Macmillan Cancer Support initiative called Next Steps, a patient-let prostate cancer support group and the Gloucestershire Hospitals NHS Foundation Trust's uro-oncology specialist nurse service. Participants will be asked to give their written consent to participate in the study. All participants will be given written and verbal information on what the study involves and will be able to ask any questions they may have. The subjects will all be informed that they may withdraw from the study at any point, without giving a reason.
Exclusion
- Any cardiovascular condition with the exception of well-controlled uncomplicated hypertension treated with no more than two drugs (either an ACE, ARB, calcium channel blocker, or diuretic)
- Cerebrovascular disease including previous stroke or aneurysm
- History of exercise-induced asthma
- Any prior history of malignancy with the exception of basal cell carcinoma of the skin
- BMI\>35 kg/m¬2
- Uncontrolled hypertension (systolic blood pressure \>160 mm Hg and/or diastolic blood pressure \>100 mm Hg after at least a 5 minute seated rest at the screening visit)
- A clinically significant ECG abnormality at the screening visit which in the opinion of the investigators exposes the subject to risk by enrolling in the trial
- Overt contraindications to exercise as determined with a normal resting ECG
- 'Yes' to any questions on a standard physical activity readiness questionnaire (PAR¬Q)
- Classification as highly physically active on the International Physical Activity Questionnaire (IPAQ)
- Inability to fully understand the verbal and written descriptions of the study in English, and the instructions provided during the study
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03308734
Start Date
May 1 2019
End Date
February 1 2020
Last Update
November 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gloucestershire Care Services NHS Trust
Gloucester, United Kingdom